« previous next »
Pages: [1]   Go Down

Author Topic: Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency  (Read 66 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 703
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
« on: January 17, 2025, 08:57:32 PM »
Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in PTPN2.
Source: Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
Logged
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)

Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
« on: January 17, 2025, 08:57:32 PM »
Pages: [1]   Go Up
« previous next »
 


Powered by EzPortal